HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association between eprosartan-based hypertension therapy and improvement in cognitive function score: long-term follow-up from the OSCAR observational study.

AbstractOBJECTIVE:
The Observational Study on Cognitive function And systolic blood pressure Reduction (OSCAR) was designed to evaluate the impact of eprosartan-based therapy on cognitive function in a cohort of 25,745 hypertensive subjects followed for six months.
METHODS:
In this supplementary analysis, we studied the relationship between eprosartan-based therapy and cognitive function (assessed using the Mini-Mental State Examination (MMSE)) after 12-month follow-up of 3600 patients (the long-term follow-up on-treatment population).
RESULTS:
Reduction in blood pressure was sustained over 12 months, with mean systolic blood pressure/diastolic blood pressure 130.9/79 mmHg at one year, compared with 164.3/92.8 mmHg at baseline (p<0.001). The overall mean MMSE score at completion of 12-month follow-up was significantly increased from baseline (27.8 ± 2.7 vs. 26.3 ± 3.5; p<0.001). The increase in MMSE score was observed when the population was stratified by age (p<0.001) and in a subgroup of patients with cerebrovascular disease at baseline (n=290) (p<0.001, 12 months vs. baseline).
CONCLUSIONS:
In this cohort of patients, use of eprosartan-based treatment for one year was associated with sustained reduction in blood pressure and stabilization or improvement of MMSE scores. These data are supportive of a role for blood pressure control in the prevention or delay of cognitive decline.
AuthorsOlivier Hanon, Yong-Seok Lee, Atul Pathak, OSCAR Publication Group
JournalJournal of the renin-angiotensin-aldosterone system : JRAAS (J Renin Angiotensin Aldosterone Syst) Vol. 16 Issue 2 Pg. 366-73 (Jun 2015) ISSN: 1752-8976 [Electronic] England
PMID23748626 (Publication Type: Journal Article, Observational Study, Research Support, Non-U.S. Gov't)
Copyright© The Author(s) 2013.
Chemical References
  • Acrylates
  • Imidazoles
  • Thiophenes
  • eprosartan
Topics
  • Acrylates (pharmacology, therapeutic use)
  • Aged
  • Aged, 80 and over
  • Blood Pressure (drug effects)
  • Cognition (drug effects)
  • Demography
  • Diastole (drug effects)
  • Female
  • Follow-Up Studies
  • Humans
  • Hypertension (drug therapy, physiopathology)
  • Imidazoles (pharmacology, therapeutic use)
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Systole (drug effects)
  • Thiophenes (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: